A missed transportation confirmation, an incomplete electronic diary, or confusion about visit preparation may appear to be an isolated participant issue. Across a complex clinical trial, these issues can become missed visit windows, incomplete assessments, protocol deviations, and avoidable withdrawals.
Protocol adherence depends on more than participant willingness. Even highly engaged participants can struggle with demanding visit schedules, travel requirements, study technology, caregiver responsibilities, and uncertainty about what is expected between visits.
Research supports looking closely at participant burden while avoiding overly broad claims about any single retention strategy. Connie Ulrich and colleagues found that cancer trial participants who had considered dropping out reported greater perceived burden and lower perceived benefit. In a separate cancer center program, Mona Fouad and colleagues found that tailored navigation was associated with greater retention among African American participants in therapeutic cancer trials.
The broader evidence also calls for restraint. A Cochrane review led by Kate Gillies found that retention strategies have been studied unevenly, with limited evidence for approaches focused specifically on clinic attendance. The appropriate support must therefore be aligned with the protocol, participant population, and specific operational barrier.
When the volume or complexity of participant coordination exceeds a site’s available capacity, dedicated participant support may help address these barriers before they interfere with continued study participation.
When Dedicated Participant Support May Be Appropriate
Not every clinical trial requires a separate participant support role. The key question is whether the protocol creates a volume or type of participant coordination that the existing site team can realistically absorb.
Dedicated support may be appropriate when a protocol includes:
- Frequent or tightly timed visits
- Significant travel or transportation requirements
- Multiple departments or service providers
- Electronic diaries, wearable devices, or virtual visits
- Substantial caregiver involvement
- Extended participation and follow-up
- A geographically dispersed participant population
Clinical research coordinators often manage these demands while also handling visit conduct, source documentation, data entry, query resolution, regulatory responsibilities, and investigational product processes.
A Clinical Trial Participant Support Specialist can provide focused operational support when participant coordination begins to compete with those core study responsibilities.
What a Participant Support Specialist Can Do
The role should be defined by the protocol, the site’s needs, and the responsibilities that can appropriately be delegated. Depending on the assignment, a Participant Support Specialist may:
- Reinforce visit schedules and preparation requirements using materials approved by the site
- Coordinate approved transportation and travel support
- Help participants prepare for remote or in-person visits
- Assist with nonmedical questions about study logistics
- Follow up on incomplete electronic diaries or other required participant activities
- Help resolve basic technology issues or connect participants with the appropriate resource
- Identify participation barriers and escalate them to the site team
- Maintain consistent contact with participants and caregivers between visits
The objective is not simply to increase the frequency of participant contact. It is to make that contact purposeful, consistent, and connected to the operational requirements of the protocol.
Clear Role Boundaries Are Essential
Participant Support Specialists do not provide medical advice, interpret symptoms, assess adverse events, make clinical decisions, or replace the clinical research coordinator.
They work within delegated responsibilities, follow procedures approved by the site, and operate under investigator and site oversight. Any medical question, reported symptom, or potential safety concern must be escalated promptly to qualified site personnel according to the site’s established process.
Training, documentation expectations, communication pathways, privacy requirements, and escalation procedures should be defined before the assignment begins.
When the role is properly structured, dedicated support can expand the site’s participant coordination capacity without creating confusion about clinical responsibility.
Adapting Support to the Protocol and Participant Population
The nature of participant support varies considerably by protocol and therapeutic area.
In rare disease studies, support may focus on complex travel, caregiver coordination, home health interactions, remote sample collection, and extended follow-up. Participants may live far from the research site and rely heavily on family members to manage study requirements.
In oncology trials, the operational challenge may involve coordinating laboratory testing, imaging, treatment visits, safety assessments, and routine clinical care. Participants may also be managing symptoms, treatment effects, and changing transportation or caregiver needs.
In studies that rely heavily on participant-facing technology, support may center on virtual visit preparation, electronic diary routines, wearable devices, and connections to technical resources.
The role should be designed around the actual sources of burden within the protocol rather than applied as a standard job description across every study.
Choosing Remote, On Site, or Combined Support
The appropriate model depends on the work that needs to be performed.
Remote support may be effective for appointment confirmation, visit preparation, routine follow-up, technology assistance, and approved logistical coordination. Support at the site may be more appropriate when participants need help navigating complex visit workflows or coordinating activities across several departments.
Some studies may benefit from a combined model, particularly when participants require both regular contact between visits and assistance during visits at the research site.
The decision should account for the protocol, site infrastructure, participant population, privacy requirements, local regulations, and the systems the specialist will need to access.
Evaluating the Operational Value
The value of participant support should be evaluated through observable study outcomes rather than broad claims about engagement or data quality.
Relevant measures may include:
- Missed or rescheduled visits
- Visit window deviations
- Completion of electronic diaries and participant-reported assessments
- Unresolved transportation or technology issues
- Participant withdrawals related to avoidable logistical burdens
- Time spent by CRCs on routine participant coordination
- Frequency and timeliness of issue escalation
These measures can help determine whether the support is addressing the operational problem it was intended to solve.
Dedicated participant support cannot correct an unrealistic protocol, insufficient site budgets, limited patient access, or weak investigator engagement. It is one practical option for addressing a defined and potentially controllable source of site burden.
Questions for Sponsors, CROs, and Sites
Before adding a Participant Support Specialist, study teams should consider:
- Which participant activities create the greatest operational burden?
- Which responsibilities can appropriately be delegated?
- What training, systems, and site access will be required?
- How will medical questions and safety concerns be escalated?
- Who will direct and oversee the specialist’s work?
Answering these questions early helps ensure that the role adds meaningful capacity instead of another layer of unclear responsibility.
The RapidTrials Perspective
RapidTrials provides protocol-aligned clinical research professionals to address defined capacity and expertise gaps at research sites. This may include dedicated participant support delivered remotely, at the site, or through a combination of both, under investigator and site oversight.
If participant coordination is consuming site capacity or contributing to avoidable execution issues, RapidTrials can help define the appropriate role, experience, and level of support.
Talent for the realities of clinical research.
